Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03527147
Title Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
Acronym PRISM
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acerta Pharma BV
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Research Site Los Angeles California 90095 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site New Orleans Louisiana 70112 United States Details
Research Site Bethesda Maryland 20892 United States Details
Research Site Omaha Nebraska 68198 United States Details
Research Site Rochester New York 14642 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Charlottesville Virginia 22908 United States Details
Research Site Seattle Washington 98104 United States Details
Research Site London W1G 6AD United Kingdom Details
Research Site Oxford OX3 7EJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field